Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187925 · ClinicalTrials.gov registry record
Cricopharyngeal Dysfunction and Esophageal Diverticulum
A clinical trial of Zenker Diverticulum and Progressive Dysphagia, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT03187925: Recruiting study of Zenker Diverticulum and Progressive Dysphagia, sponsored by University of Cincinnati.
NCT03187925 is a study of Zenker Diverticulum and Progressive Dysphagia that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03187925, a study of Zenker Diverticulum and Progressive Dysphagia, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients undergoing open transcervical or endoscopic approach in which a laser or stapler is used to divide the common wall between the diverticulum and esophagus, or who are not surgical candidates but agree to follow-up.
Primary Outcome
Demographic data will be summarized for categorical and continuous measures. Continuous data will be compared between groups using student's t-test.
Conditions Studied
Interventions
- PROCEDURE open, transcervical versus rigid endoscopic treatment
Study Locations (1)
Ohio
- UC Health Otolaryngology-Head and Neck Surgery - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-08-15 |
| Est. Completion | 2027-06 |
What NCT03187925 shows while recruiting
NCT03187925 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 3 conditions, with Zenker Diverticulum appearing as the primary indexed condition, and to 1 intervention - of which open, transcervical versus rigid endoscopic treatment is the first listed.
NCT03187925 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03187925 about?
NCT03187925 is a clinical study titled "Cricopharyngeal Dysfunction and Esophageal Diverticulum". Patients undergoing open transcervical or endoscopic approach in which a laser or stapler is used to divide the common wall between the diverticulum and esophagus, or who are not surgical candidates but agree to follow-up.
What is the current status of trial NCT03187925?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-08-15. Estimated completion is 2027-06.
What conditions does trial NCT03187925 study?
This clinical trial studies the following conditions: Zenker Diverticulum, Progressive Dysphagia, Pharyngoesophageal Diverticulum.
What interventions are being tested in trial NCT03187925?
The interventions under investigation include: open, transcervical versus rigid endoscopic treatment (PROCEDURE).
Who is sponsoring clinical trial NCT03187925?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03187925 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Zenker Diverticulum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI